How will you navigate the new ema regulations targeted for 2017?
join us for this unique opportunity to collaborate with industry experts and peers.
EMA Pharmacovigilance Readiness Webinar
Watch the recording!
European pharmacovigilance legislation, updated and amended over the past five years, are targeting 2017 for a series of wide ranging changes to case management and reporting regulations, including electronic reporting with E2B (R3), adoption of IDMP and centralized reporting to the EMA.
Conforming to these new regulations will require pharmaceutical companies to consider organizational, functional and technical changes in the coming months. How far reaching are these regulations and how may your company’s pharmacovigilance group be impacted? Join us on July 21st, 2016 at the EMA Pharmacovigilance Readiness Webinar hosted by HighPoint Solutions to learn more about what your organization needs to do to be ready.
About Our Presenter: Amy Bosch, Principal Pharmacovigilance Consultant
Amy has more than 20 years of experience in the biotech and pharmaceutical industry, having worked in both pharmacovigilance and regulatory affairs at global and emerging companies. Amy brings the ability to interpret and clarify regulatory guidelines and regulations in order to develop compliant pharmacovigilance processes and manage safety data using commercial software systems.